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W e exa mined parti al thickness in cised human wounds of 
2 , 3, 5, 7, and 14 days o f age fo r the presence o f throm-
bo~pondin by immun os tainin g and light microscopy. At 
2 , 3, 5, and 7 da ys after w oundin g, thrombospondin is 
p resent prim arily at the cut edges o f the lateral and deep 
m argins of the wound. It appea rs to be clea red fro m these 
extracellul ar matri x sites, and is no longer detectable in 
those sites in most 14-day-old wounds . Thrombospondin 
s taining is present, however, in increased am ounts around 
th e vascular channels within and adjacent to the 7- and 14-
T hro mbosPolldin , a high m olecular wcight g lyco pro-tein , is a maj o r componcnt o f platelet alpha g ranul es [1-4]. Wh en platclets are acti vatcd , the contents o f th c alpha .. g ranul es arc released into thc ex tracellul ar milicu. Platelet thrombos pondin can bind to fibrin-
ogen and beco me inco rpo rated into the fibrin clo t [5,6]; throm-
bospondin also binds to components o f thc ex tracellul ar matri x 
(ECM) [7-1 0]. 
Thrombos pondin has been shown to be sccretcd and inco r-
porated into the EC M by cndothclial cclls [8,9,11] , vascul ar smooth 
muscle cells [8, 12], derm al fibroblas ts [8, 13 1, melanocytcs [14], 
macrophagcs /15 ,16], alveo lar type II pneum ocy tes [1 7], and 
m esan gial cell s (G Raugi, DH Lovett; in prcss) in culture . 
T hrombospondin binds spccificall y to fibrin ogen and fibrin [5,6, 18] 
an d to ce rtain components o f th e ECM such as heparin [7], fi-
broncctin [1 0, 19], laminin /1 0], and type V co llagen [1 0]. Throm-
b ospondin may playa role in platelet aggrega tion [13,20], but its 
role in the cx tracellular matri x is not understood. Reccntl y, we 
h ave dem onstrated the presence of thrombos pondin at thc dcr-
m al-epiderm al junction o f no rmal hum an skin , in the matri x 
s urrounding no rmal blood vcssels, and in thc bascment mcm-
brane zonc of the eccrine apparatu s [21] . T he rate o f thrombo-
spondin secrction by cultured cnd o thelial cells and WI-38 lung 
fi broblasts is dependent on the dcg ree of cellular confluency and 
pro liferative status o f th e cclls. Proliferatin g cells secretc morc 
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Abbreviations: 
ECM : ex tracellular matrix 
ELI SA: enzy m e- lin ked immun osorbcllt assay 
PDGF: platelet-deri ved g rowth fa cto r 
SDS- PAGE: sodium dodecy l sul fate- po lyac rylamide gel 
electropho res is 
T SP: throm bospondin 
day wounds in in creased amounts relative to vascular chan-
nels di stant from the w ound. Our observations are con-
sistent with known in vitro data rega rdin g the bindin g o f 
thrombospondin to fibrin and components of th e ex tra-
cellular matrix, as w ell as w ith data showing th at prolif-
erating endothelial cells secrete mo re thrombospondin than 
quiescent endothelial cell s. These data suppo rt the hypoth-
es is th at thrombospondin plays a role in the ea rl y orga-
niza tion of the ex tracellular matrix o f wounds. J Invest 
D eI'I l/atof 89:551-554, 1987 
thrombos pondin per cell than do quiescent cells in conflucnt cu l-
tures. Secrcti on of fibron ectin and co ll agen was found, in contras t, 
to be independent of ccll density [22]. 
Sill ce an ea rl y woun d is fill ed with a fibrin clot and exposes 
the extraccllul ar matrix to produ cts released fro m acti va ted platc-
lcts, it was o f intcrcs t to know w heth er thrombospondin was 
present in such wounds, how rapidl y it w as clca rcd from the 
wound , and w hcther vascular structures in and nea r thc hea ling 
dermi s would contain thrombos pondin . 
In this stud y, antibod ies to thrombospondin bound promi-
nentl y at the lateral and dccp m argins o f ea rl y partial thi ckn ess 
hum an skin wounds. T wo weeks after woundin g, the vcssels 
adj acent to wo unds and vascul ar channels w ithin wo unds showed 
grea ter intensity of thrombos pondin antibody staining than did 
no rm al vesscls di stant fro m th e wo und. Staining was, fo r the 
most part, howevcr, absent from other arcas o f wound bcd staincd 
in ea rli er wounds. The specifi city o f anti-thro mbospondin an ti-
body binding was shown by blocking expcrim ents using fibrin-
ogen, fibronectin , o r tl1rombos pondin . 
MA TE RIALS AND METH ODS 
Selection of Patients T en hea lth y m ale volunteers ranging in 
age from 59- 73 years were recruited by placin g an advertisement 
in a dail y newspaper. Volunteers w ith a history o f cardi ovascular 
disease, hypertension, diabetes , smokin g in the pas t ten yea rs, o r 
alcoho lism were excluded from the stud y. Info rm ed consent was 
obtained in accordance w ith the University of Washing ton Hu-
man Subjects Institutional Review Boa rd . 
Wounding Technique, Specirrlen Collection, and Process-
ing A Simplate-II bleeding-time dcvice was used to crea te pairs 
of parti al thickness wounds under sterile conditions on th e lateral 
surface o f the leg, approximatel y 10 cm distal to th e patella. Each 
subj ect had three pairs of mi crowounds crea ted; one pair 14 days 
prio r to biopsy, onc pair 7 days prio r to biopsy, and one pair 
either 2, 3, o r 5 days prio r to biopsy. 
Thc stud y repo rted hcrein was part o f a larger stud y of wound 
morphology and immunocy tochcmistry of wounds in the elderl y. 
Allmicrowounds we re removcd from each volunteer at th e sa me 
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ti~e usin g a standard 4-m m punch bio psy to the depth of sub-
cutaneous fa t. Bio psies were bisected under a d issectin g m icro-
scope using g reat ca re to di vide biopsies perpendicular to th e 
microwoun ds. O n e half of each wound was processed fo r electio n 
mi crosco py. T he o th er half was placed in organ cL1lture m edium , 
m eth yl-Ca rnoy's fi x tati ve, o r OCT. T he 21 specimens placed in 
m eth yl-Ca rn oy's were used fo r the immuno hi stochemica l studies 
th at fo rm the bas is fo r this report. These tissue samples were 
fi xed , processed, embedded in paraffin , and sectio ned approxi-
m ately 6 J.l.m thick . All w ere eva luated , but 4 wounds (ages 2, 3, 
7, and 14 days) disrupted in processing were excl uded. H ence, a 
to tal of 17 bio psy speci m ens were th o ug ht to be comparable fo r 
tempo ral eva luatio n of the presence of thro mbospondin antigen. 
Immunocytochemistry T he avidin-bio tin immunoperoxid ase 
procedure of H su and colleagues [23], usin g the ni ckel chl o ride 
m od ifi ca tio n and intensifi ca tion schem e of H su and Soban [241, 
as m od ified and prev io usly described by Gown and Vogel [25], 
was used for th e antibody loca lizatio n studies . Reagents w ere 
o btained fro m Vecto r Labo rato ri es (Burlinga m e, Ca lifo rnia) . Sec-
ti ons were counterstain ed with m eth yl g reen in o rder to aid III 
identifi ca ti on of cell types. 
Antiserum to human platelet thro mbos po ndin was raised III 
rabbits and has been characterized elsew here [8]. The IgG frac ti on 
of th e rabbit antiserum afte r immunoaffinity adso rption on a 
column of plasm a flbronectin-Sepharose contain ed substan tial ac-
ti vity against th ro mbos pondin, minimal activity aga inst fib ro-
nectin and fibrin ogen , and no activity aga inst collagen types I, 
1II , IV , and V . Activity of the purifi ed antiserum was tes ted usin g 
an enzym e-linked immunoso rbent assay (E LISA) as described 
befo re [8]. 
Preparation ofThrombospondin Thro mbospondin w as pre-
pared fro m w as hed hum an platelets o btained fro m the Puget 
Sound Blood Center. Platelets were activated with the calcium 
iono pho re A23187 (10 J.l.M) . The hi gh-speed supernatant frac ti on 
was subj ected to gel filtrati on chro m atograph y and hepa rin-Se-
pharose affinity chro m atograph y using previously described 
m ethods [7,8, 11], except th at 1 mM CaCI2 was present in all 
buffe rs. T he purity o f indi v idu al preparati ons was assessed by 
sodium dodecy l sul fa te-po lyacrylamid e gel elect ropho resis (SDS-
PAGE) before and afte r redu cti on w ith 2-mercaptoeth ano l. 
Preparation of Fibronectin and Fibrinogen Plas m a fibro-
nectin w as prepared fro m hum an plas m a by affinity chro m atog-
raph y on gelatin-Sepharose [26]. Fibrinogen w as purchased from 
Sig m a C hemi cal C o . (St. Lo uis, Missouri) . Contamin atin g fi-
bronectin w as rem oved by affinity chromatography on gela tin-
Sepharose. Purity o f the fin al products w as assessed by SDS-
PAGE befo re and after reductio n w ith 2-merca ptoethano l. 
Blocking of Antiserum Blocking experiments w ere con-
du cted to tes t th e specifi city of thrombospondin antibody bindin g 
in th e tissue. A 1 : 50 dilution o f antiserum , prepared in a bu ffer 
con ta inin g 50 mM Tris-H C I, 150 mM N aC I, 1 mM CaClz, 0. 1 % 
Tween 20, 0.02% N aN ), and 0. 1 % bo vin e serum albumin , w as 
used as the contro l. In blockin g experim ents, soluti ons of th e tes t 
antigen were added to the indi ca ted fin al concentrati on , w ith the 
antiserum concentrati ons rem ainin g constant at 1 : 50. These mix-
tures were in cubated for 2 h o r longer before being tes ted fo r 
residual binding ac ti vity to thrombos pondin bo und to polysty-
rene m icro titer pl ates, o r fo r residual binding activity to tissue 
sections. The antigens preincubated with antith rombospondin were 
fibrin ogen, fibronectin, or throm bos pondin. 
RES ULTS 
Distribution of Thrombospondin in Dermal Wounds In 
2- ,3- ,5- , and 7- da y wo unds, thrombospondin anti gen w as pres-
ent pro min entl y in th e dermis along the lateral and deep m argins 
of the w ounds (e.g . , Fig 1 A, C). This immunostaining pattern w as 
judged to be definite or strong in a 2-day wound (1 of 1), two 
3-day wounds (2 o f 2) , two 5-day w ounds (2 o f 2) , and fi ve 7-
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day woun ds (5 of 6). The presence of reaction prod uct was thought 
to be equi voca l in th e extracellular m atrix area at the late ral an d 
deep wound m argins of the six th 7-day wound but strong around 
vessels at the wound m argin . In fi ve of the 14-day w ounds (5 of 
6), thro mbospondin antibod y was alm ost entirely absent fr om 
th e extracellul ar m atri x areas at lateral and deep w o und m argi ns 
(Fig 1 E) w here it was loca lized in the ea rlie r wounds. The vascular 
channels at the wound ed ges an d in the new g ranulation tissue, 
however, stained definite o r strong fo r thro mbos po ndin in 5 of 
6 wound s. O ne wound showed stainin g of bo th blood vessels 
and wound m argins. The immunostainin g aro und blood vessels 
in 14- day wounds was considerabl y m o re intense than th at present 
aroun d th e derm al vessels di stant fro m th e wound in the sa m e 
tissue section. Thi s vascular immunos tai n ing pheno m enon was 
generall y o bserved in 7-day wounds (4 o f 6) as well as 14-day 
wounds (Fi g 1 D , F) but was onl y faintl y present in 2 of 5 ea rlier 
wounds. The thrombos pondin ap pea red to be present in the en-
do thelium and adj acent conn ecti ve tissue. 
The di st ributio n o f immuno reactive thro mbospondin in th e 
skin distant from the wound was similar to th at previously o b-
served in no rm al skin [21]. Thrombospondin antibodies bound 
at the dermal-epidermal juncti o n on m ost tiss ue sectio ns. In so m e 
secti ons, th e immunos tainin g was wea k and discontinuous. T he 
basem ent m embrane zone of the eccrin e apparatus bo und anti-
body to thro mbos po ndin , but often no t all th e coils in a sweat 
g land were st:l ined . The derm al blood vessels we re also weakl y 
pos iti ve w ith the th ro mbospondin ant ibod y. 
Blocking Experiments Beca use of the possibility that the 
immunos taining we o bserved mig ht have been due to adventi-
ti ous binding o f an antibod y no t directed aga inst th ro mbospon-
din , we perfo rm ed blockin g ex perim ents to in crease our confi -
dence in the specifi city o f immunos tainin g. Prein cubation of 
in creas in g amounts of thr.o mbos po ndin with a 1 : 50 dilution of 
antiserum resulted in blockin g of up to 90% o f th e anti body 
acti vity aga inst thrombospondin as tes ted b y ELISA . Equi va lent 
am o un ts (on a weig ht bas is) of fl bronectin o r fibrin ogen had no 
effect on subsequent binding o f antibod y to th rombospondin 
(Fig 2) . 
Si milarl y, thro mbos po ndin co mpletely blocked binding o f the 
th ro mbospo ndin antibody to th e wound tiss ue (compare Fi g l A 
w ith B). Fibrinogen and fib ronectin did no t block tissue binding 
of thr0 111bospondin antibo dy to wound tissue. We conclude, 
therefo re, that im111un os tainin g we o bserved is du e to specific 
binding to th ro mbospondin. 
DISC U SSI O N 
Thro mbospondin is a g lycopro tein of 450,000 dalto ns consistin g 
of three pro babl y identical chains held together by disulfide bridges 
(fo r review see [27J) . Altho ugh it is one o f the principal pro teins 
re leased from the alpha g ranules o f activa ted pl atelets, its fun ctions 
are inco mpletely understood . In the presence o f calcium, th ro lll-
bospondin binds to the surface of activated pl atelets [20], and 
appea rs to fun ction as the endogenous platelet lectin [13]. 
The di scovery that thro mbos pondin is a secretory product of 
many cells in culture and that newl y synthesized thrombos pondin 
m ay becom e associated with the extracellul ar matrix has led to 
consideration o f a wider role for this pro tein . The fll1din g that 
the regulation of secretion of thrombos pondin by cultured cells 
was different than the control o ffibron ectin o r collagen , suggested 
th at thrombospondin secreti on m ight be an event associated w ith 
cellul ar proliferation o r migratio n in respo nse to tissue injury [22]. 
This hy pothesis was supported by M aj ack and colleagues [1 2], 
who demonstrated that th rombospondin secretion w as stimulated in 
vascul ar smooth muscle cells cultured in g ro wth factor-defi cient 
m edium by the addition of pl atelet-derived growth factor (PDGF). 
O ur experim ents show that thrombospo ndin is present at the 
cut edge o f a dermal wound within the first two days afte r w ound-
in g. These results are consistent with published data showing that 
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Figure 2. Abso rbance (405nm) developed by the alkaline phosphatase 
co njuga te detectin g thrombospondin antibody binding to micro titer wells 
coa ted with thrombospandin . The thrombospondin antibody in this ex-
periment had been preincubated with the indicated concentrations of fi -
brinogen, fibronectin , o r thrombospondin prior to application to the 
microtiter wells. On ly thrombospondin in concentrations grea ter than 10 
J.Lg/ml significantl y blocks the thrombospondin antibody demonstratin g 
the specifici ty of the antibody relative to the other ligands tes ted. 
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Figure 1. Photomicrographs of iml1lunolocaliza-
tion studies of thrombospond in on sections of hu-
man woun d ti ssue. A, Section of three-d~y-old 
wound stain ed with rabbit antibody to human 
platelet thrombospondin . Reaction products dark ly 
stain the lateral and deep dermal wound margins . 
Fa int illlmunostaining at the basement membrane 
zone is noted in adjacent skin (55X; Ba l' , 200/1-m ). 
B, A cont ro l section from the saille three day old 
wound shown in A was immunostained with 
thrombospondin anti bodies whi ch had been prca b-
sorbed with thrombospondin (450 /1-g/ ml). Note 
that rcaction produ cts are no longer present in the 
wound or adjacent dermis (55X , Bar, 200/1-m). C, 
Seven-day-old wound showing loca lization of 
thrombospondin antibodies along the wound edge 
(e), in a dense fibrin co llection in the wound bcd 
en surrounding dermal blood vesse ls (,,) and swea t 
coils (5) . Magnifi cat ion 55X, bar, 200/1-m . D, A 
higher magnification (88X; Bar, 200/1-m) of the same 
sec tion shown in C . T he blood vessels adjacent to 
the wound (II) show a g rea ter intensiry of 
imlllunos tainin g than the vessels 1110 re distant from 
the cut edges (II). E, Fourteen-day-old wound shows 
the thrombospond in antigen is no longer predom-
inantl y ex trace llul ar at the late ral and deep de rm al 
wound edges , but reaction product pro minentl y 
decorates the blood vessels ( II) near the wound and 
in the g ranulation ti ssue. A ];lrge lymph channel 
(L) has much less immunostainin g (55X, Bar, 
200/1-m ). F, Sa me sec tion as E, showing detail of 
de rmal vesse ls. Note the difference in amou nt of 
rcaction product associated with dermal vessels in 
or nca r the wound ( II) versus those furth er away 
(II) (88X; Bar, 200/1-11'1 ). 
thro mbos po ndin binds to fibrin ogen and fibrin [5 ,6, 18], as well 
3S o ther co mpo nents of the extracellular matri x 1'9, 10). T he dis-
tributio n of thro mbospondin in th e 2- , 3- , 5- , and 7-day- old 
wounds pro babl y refl ects depos iti o n resulting prim arily from 
p la te le t acti va tion rather than ne w synth esis fro m dermal fibro-
bl as ts. M cKeown-Lo ngo and coworkers 1.28] have sugges ted that 
thro mbospondin plays a tran sitory ro le in th e formatio n o r o r-
ga ni zatio n o f the EC M . This v iew is suppo rted b y o ur o bser-
vations th a t immuno reactive thrombosp o ndin in th e immedia te 
woun d area was essentiall y undetecta ble in 14-day wounds except 
in re la tio nship to blood vessels. W e did no t o bserve sig nifi ca nt 
cytoplas mic illlnlunostainin g for TSP antigen in o th er derm al 
cells o r keratinocy tes even thoug h fibro b las ts [8, 13], m o nocy tes 
[1 5 , 16], and keratin ocytes [29] a re kn ow n to prod u ce TSP in 
cul ture . 
The neovascul ar chann els in the reg io n o f the hea lin g w ound 
s tain ed s tro n g ly for thro lllbospondin , in cont rast to no rm al vas-
cular s tru ctures so mew h at rem oved fro m the wound in th e sam e 
tissue sections. T hese neovascula r chann els , a t least in ce ll culture 
m odels, are co mposed primari ly of mi g ratin g endothelia l ce ll s 
[30], alth o ug h pro li fera ti o n ma y be an impo rtant secondary fac-
tor. Althou g h o ur stud y does no t directl y address the o rig in o f 
th e TSP an tigen o bserved in these tissue section s, the specifi city 
o f th e dis tribution of th e antigen in 14-day wound s suggests an end o-
th eli a l or ig in . In creased synthesis of throlll bos pondin by prolif-
erati ng and mig ratin g endothelia l ce lls h as been d em o nstrated in 
cell culture ex perim ents [22J. O ur results are the refore in accord 
w ith in vitro d ata, and a re consistent w ith the hy pothesis that 
thro lllbospondin secre tion is part of the phenotype of proli fer-
ating o r mig ratin g cell s. 
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